SCHEMBL7303095

SCHEMBL7303095

O=C(COP(=O)(c1ccccc1)c1ccc(Cl)cc1)COP(=O)(c1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPT P10636 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3893770 0.89 MEN1 (0.55) KMT2AMEN1ALDH1A1GAAMAPT
SCHEMBL7304302 0.85 KMT2A (0.47) KMT2AMEN1ALDH1A1GAAMAPT
SCHEMBL7308253 0.81 ACP3 (0.47) KMT2AMEN1ALDH1A1GAAMAPT
SCHEMBL27510315 0.78 MEN1 (0.47) KMT2AMEN1ALDH1A1CYP1A2GAA
SCHEMBL28449328 0.76 KMT2A (0.49) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL7308021 0.74 LMNA (0.48) KMT2AMEN1ALDH1A1GAANPC1
SCHEMBL28441070 0.72 POLB (0.59) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL10522698 0.69 CYP1A2 (0.52) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL4378891 0.69 MEN1 (0.76) KMT2AMEN1ALDH1A1GAAALOX12
SCHEMBL2870880 0.69 CYP1A2 (0.52) KMT2AMEN1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843905-A Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-01 — — US claimed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 — — EP claimed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 — — EP claimed
US-5843905-A Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-01 — — US disclosed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 — — EP disclosed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 — — EP disclosed
Send feedback